All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

382

Reset

382 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • AZD7789Phase 21 trial

    AstraZeneca · Carcinoma, Non-Small-Cell Lung, Gastric Cancer, Gastroesophageal Junction Cancer

  • AZD8205Phase 21 trial

    AstraZeneca · Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer

  • BalstililmabPhase 21 trial

    Nelum Corp · Untreated, Advanced Pancreatic Cancer

  • BDC-4182Phase 21 trial

    Bolt Biotherapeutics, Inc. · Gastric Cancer Adenocarcinoma Metastatic, Gastroesophageal Adenocarcinoma

  • BHB810Phase 21 trial

    BigHat Biosciences, Inc. · Gastric Cancer, Gastric Adenocarcinoma, Gastric (Stomach) Cancer

  • BI 3802876Phase 21 trial

    Boehringer Ingelheim · Liver Cirrhosis

  • BI 770371Phase 21 trial

    Boehringer Ingelheim · Compensated Liver Cirrhosis, Metabolic Dysfunction Associated Steatohepatitis (MASH)

  • BLU-924SAR449336Phase 21 trial

    Blueprint Medicines Corporation · Advanced Solid Tumor, Non-Small Cell Lung Cancer, Colorectal Neoplasms

  • BMS-986523Phase 21 trial

    Bristol Myers Squibb · Advanced Solid Malignancies, Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)

  • BPI-572270Phase 21 trial

    Betta Pharmaceuticals Co., Ltd. · Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC)

  • CBX-12Phase 21 trial

    Cybrexa Therapeutics · Solid Tumor, Adult, Epithelial Ovarian Cancer, Small Cell Lung Carcinoma

  • certepetideCEND-1, LSTA1Phase 21 trial

    Lisata Therapeutics, Inc. · Cholangiocarcinoma, Gallbladder Cancer, Gallbladder Carcinoma

  • CGT4859Phase 21 trial

    Cogent Biosciences, Inc. · Intrahepatic Cholangiocarcinoma (Icc), Cholangiocarcinoma, Other Solid Tumors, Adult

  • CNP-104Phase 21 trial

    COUR Pharmaceutical Development Company, Inc. · Primary Biliary Cholangitis

  • CP-383Phase 21 trial

    Tasca Therapeutics · Solid Tumor Malignancies, Colorectal Carcinoma, Small Cell Lung Cancer ( SCLC )

  • CPT-11Phase 21 trial

    Zhejiang Doer Biologics Co., Ltd. · Gastrointestinal Cancer

  • CR-002Phase 21 trial

    Crescent Biopharma, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Gastric/GEJ, Biliary Tract Cancer (BTC)

  • CSG452Phase 21 trial

    Kowa Research Institute, Inc. · NASH

  • CT041Phase 21 trial

    CARsgen Therapeutics Co., Ltd. · Gastric Cancer, Pancreatic Cancer

  • CT3001Phase 21 trial

    Crossignal Therapeutics, Inc. · Solid Tumor, Adult, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma

  • DB-1324Phase 21 trial

    DualityBio Inc. · Gastrointestinal Cancer

  • DCC-3009Phase 21 trial

    Deciphera Pharmaceuticals, LLC · Gastrointestinal Stromal Tumor (GIST)

  • DD01Phase 21 trial

    Neuraly, Inc. · NAFLD, NASH

  • Decoy20Phase 21 trial

    Indaptus Therapeutics, Inc · Solid Tumor, Adult, HCC - Hepatocellular Carcinoma, CRC (Colorectal Cancer)

  • DM002Phase 21 trial

    Xadcera Biopharmaceutical (Suzhou) Co., Ltd. · Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

  • DONQ52Phase 21 trial

    Chugai Pharmaceutical · Celiac Disease

  • DR30206Phase 21 trial

    Zhejiang Doer Biologics Co., Ltd. · Gastrointestinal Cancer

  • E7090Phase 21 trial

    Eisai · Cholangiocarcinoma

  • E7386Phase 21 trial

    Eisai · Endometrial Neoplasms, Neoplasms, Carcinoma, Hepatocellular

  • ECC0509Phase 21 trial

    Eccogene · Metabolic Dysfunction-associated Steatohepatitis

  • EF-009Phase 21 trial

    Everfront Biotech Co., Ltd. · Pancreatic Cancer

  • EfineptakinNT-I7, rhIL-7-hyFcPhase 21 trial

    NeoImmuneTech · Any Advanced Solid Tumors, Triple Negative Breast Cancer, Non Small Cell Lung Cancer

  • efocipegtrutideHM15211Phase 21 trial

    Hanmi Pharmaceutical Company Limited · NASH - Nonalcoholic Steatohepatitis

  • EGEN-5784Genetically Engineered Porcine Liver, xenogeneic porcine liverPhase 21 trial

    eGenesis, INC · Acute on Chronic Liver Failure (ACLF), Hepatic Encephalopathy (HE)

  • EIK1005Phase 21 trial

    Eikon Therapeutics · Advanced Solid Tumors, MSI-H or dMMR Advanced Solid Tumors, MSI-H/dMMR Gastric Cancer

  • EP-104GIPhase 21 trial

    Eupraxia Pharmaceuticals Inc. · Eosinophilic Esophagitis

  • ERAS-0015Phase 21 trial

    Tango Therapeutics, Inc. · PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC

  • ETX-929Phase 21 trial

    Ensem Therapeutics · Metastatic Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Non-squamous, Non-Small Cell Lung Cancer

  • F573Phase 21 trial

    Beijing Continent Pharmaceutical Co, Ltd. · Acute Liver Failure, Acute-On-Chronic Liver Failure

  • FB102Phase 21 trial

    Forte Biosciences, Inc. · Celiac Disease

  • gavo-celPhase 21 trial

    TCR2 Therapeutics · Mesothelioma, Mesothelioma, Malignant, Mesothelioma; Pleura

  • GEN1042Phase 21 trial

    Genmab · Malignant Solid Tumor, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)

  • GFS202APhase 21 trial

    Genfleet Therapeutics (Shanghai) Inc. · Pancreatic Cancer

  • GI-108Phase 21 trial

    GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Non-small Cell Lung Cancer (NSCLC)

  • GNS561Phase 21 trial

    Genfit · Cholangiocarcinoma

  • GTAEXS617REC-617Phase 21 trial

    Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Pancreatic Adenocarcinoma, Non-small Cell Lung Cancer (NSCLC)

  • HCW9218Phase 21 trial

    ImmunityBio, Inc. · Advanced Pancreatic Carcinoma

  • HK-660SPhase 21 trial

    CuromeBiosciences · Primary Sclerosing Cholangitis (PSC)

  • HMBD-001Phase 21 trial

    Hummingbird Bioscience · Advanced or Metastatic Squamous Non-Small Cell Lung Cancer, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Esophageal Squamous Cell Carcinoma

  • HP515Phase 21 trial

    Hinova Pharmaceuticals Inc. · NAFLD (Non-alcoholic Fatty Liver Disease)

NewerPage 6 of 8Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.